Technique May Offer Alternative To Radiotherapy, Avoid Side Effects
High-intensity focused ultrasound ablation has long been proposed for the treatment of solid tumors in several organ systems. Advocates say it offers a credible nonsurgical treatment alternative to radiotherapy.
Now, high-intensity focused ultrasound's value has been established for treating prostate cancer, with positive outcomes lingering for at least five years.
Urologist Dr. Andreas Blana and colleagues at the University of Regensburg's St. Josef Hospital in Germany evaluated 140 patients (mean age 69.1) with early or intermediate localized prostate cancer. They were treated with high-intensity focused ultrasound.
During a mean follow-up of 6.4 years, either an increase in prostate-specific antigen levels or positive biopsy sampling was considered as evidence of treatment failure.
Results, published online in European Urology in November, indicated that follow-up prostate biopsies were negative in 86.4% of patients, with a five-year prostate-specific antigen-related failure-free survival rate of 77%. The overall disease-free rate at five and seven years was 66% and 59%, respectively.
"This treatment is an excellent option for men with localized prostate cancer, and it should be part of a doctor's armory when treating the disease," he said.
On 28 February 2008, Blana published another online study in Urology about factors predicting formation of bladder outlet obstruction after HIFU in treating localized prostate cancer.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.